14th Jun 2021 10:56
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | Ordinary Share |
Date of dealing | 11 June 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
204,927 | 10.5300 GBP | 10.4600 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
236,535 | 10.5247 GBP | 10.4595 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
| 6,671 1,830 17 18,319 156 1,347 3,893 2,062
178
112 313 32,023 4,701 1,848 1,218 2,062
962 1,600 1,438 | 10.4765 GBP 10.4771 GBP 10.4800 GBP 10.4874 GBP 10.5002 GBP 10.5003 GBP 10.5006 GBP 10.5254 GBP
10.4596 GBP
10.4595 GBP 10.4598 GBP 10.4600 GBP 10.4797 GBP 10.5194 GBP 10.5197 GBP 10.5247 GBP
10.4608 GBP 10.4684 GBP 10.4830 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 14 June 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L